Clinical Trial Update: Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates atezolizumab given before and/or with chemoradiotherapy in node-positive stage IB2, II, IIIB, or IVA cervical cancer. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2023-07-20